ARCHIVES

Did Iressa Data Merit Approval? Experts Discuss Implications For Drug Development, Lung Cancer Treatment, Reimbursement (12-page issue).

This article is from The Cancer Letter archive.

Vol. 29 No. 19 | May 9, 2003

Download PDF Visit The Full Archive

Related Articles

Progress Requires More Etiologists, D’Angio Says

September 15, 1978

Older Women More Likely To Receive Lower Chemotherapy Doses, Study Finds

August 28, 2009

In Brief: Holland Retires As Center Director, Replaced By NCI’s Aaronson; Lab Chiefs Leaving NCI

September 24, 1993

DeVita: “The War On Cancer Is Dead”

June 11, 2010

NCAB Settles PDQ Controversy; More CCOP Awards May Be Made, Center Guidelines Revisions Coming

October 7, 1983

NCI Advisory Group, Other Cancer Meetings

August 26, 1977